|4Mar 15, 7:09 PM ET

Lion Biotechnologies, Inc. 4

4 · Lion Biotechnologies, Inc. · Filed Mar 15, 2016

Insider Transaction Report

Form 4
Period: 2016-03-11
Bender James G.
Vice President, Manufacturing
Transactions
  • Award

    Stock Option (right to buy)

    2016-03-11+30,00030,000 total
    Exercise: $5.05Exp: 2026-03-11Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The option will vest as to 10,000 shares on March 11, 2017, and the remaining 20,000 shares will vest quarterly over the next two years after March 11, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT